Your browser doesn't support javascript.
loading
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study.
Overman, Michael J; Gelsomino, Fabio; Aglietta, Massimo; Wong, Mark; Limon Miron, Maria Luisa; Leonard, Gregory; García-Alfonso, Pilar; Hill, Andrew G; Cubillo Gracian, Antonio; Van Cutsem, Eric; El-Rayes, Bassel; McCraith, Stephen M; He, Beilei; Lei, Ming; Lonardi, Sara.
Afiliação
  • Overman MJ; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA moverman@mdanderson.org.
  • Gelsomino F; Department of Oncology and Hematology, University Hospital Modena, Modena, Italy.
  • Aglietta M; Department of Medical Oncology, Istituto di Candiolo, FPO IRCCS, Candiolo, Italy.
  • Wong M; Department of Medical Oncology, Westmead Hospital The Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia.
  • Limon Miron ML; Hospital Universitario Virgen del Rocio, Sevilla, Andalucía, Spain.
  • Leonard G; Medical Oncology, University College Hospital, Galway, Ireland.
  • García-Alfonso P; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Hill AG; Tasman Oncology Research, Ltd, Southport, Queensland, Australia.
  • Cubillo Gracian A; Hospital Universitario HM Sanchinarro, Centro Integral Oncológico Clara Campal HM CIOCC, Madrid, Spain.
  • Van Cutsem E; Department of Digestive Oncology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Belgium.
  • El-Rayes B; Department of Medicine, Emory University Hospital, Atlanta, Georgia, USA.
  • McCraith SM; Department of Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA.
  • He B; Department of Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA.
  • Lei M; Global Biostatistics and Data Science, Bristol Myers Squibb Co, Princeton, New Jersey, USA.
  • Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy.
J Immunother Cancer ; 12(5)2024 May 31.
Article em En | MEDLINE | ID: mdl-38821718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Instabilidade de Microssatélites / Nivolumabe Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Instabilidade de Microssatélites / Nivolumabe Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos